To investigate if the loss of MYC expression was due to a decreased stability of MYC protein with FGFR1 inhibition, we treated MCL cells with cycloheximide and determined that MYC degraded faster in the presence of erdafitinib (Fig. 6D-E). Here, MYC is linked to mantle cell lymphoma.